S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
Log in
NASDAQ:CRIS

Curis News Headlines

$9.47
+0.34 (+3.72 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.25
Now: $9.47
$9.54
50-Day Range
$8.99
MA: $10.56
$12.80
52-Week Range
$0.62
Now: $9.47
$13.44
Volume1.88 million shs
Average Volume2.06 million shs
Market Capitalization$557.00 million
P/E RatioN/A
Dividend YieldN/A
Beta3.29

Headlines

Curis (NASDAQ CRIS) News Headlines Today

Source:
SourceHeadline
Curis (NASDAQ:CRIS) Stock Price Down 6%Curis (NASDAQ:CRIS) Stock Price Down 6%
americanbankingnews.com - March 4 at 7:38 PM
Curis to Present at HC Wainwright & Co. Global Life Sciences Conference - PRNewswireCuris to Present at HC Wainwright & Co. Global Life Sciences Conference - PRNewswire
prnewswire.com - March 2 at 12:00 PM
Curis (NASDAQ:CRIS) Shares Up 6%Curis (NASDAQ:CRIS) Shares Up 6%
americanbankingnews.com - March 1 at 9:00 PM
Curis: Differentiated IRAK4 Inhibitor To Drive Value Creation In The Near Term - Seeking AlphaCuris: Differentiated IRAK4 Inhibitor To Drive Value Creation In The Near Term - Seeking Alpha
seekingalpha.com - March 1 at 3:54 PM
Head-To-Head Comparison: Curis (NASDAQ:CRIS) & Replimune Group (NASDAQ:REPL)Head-To-Head Comparison: Curis (NASDAQ:CRIS) & Replimune Group (NASDAQ:REPL)
americanbankingnews.com - February 27 at 2:08 AM
Reviewing Curis (NASDAQ:CRIS) and VIA Pharmaceuticals (OTCMKTS:VIAP)Reviewing Curis (NASDAQ:CRIS) and VIA Pharmaceuticals (OTCMKTS:VIAP)
americanbankingnews.com - February 21 at 12:12 AM
Curis to Present at SVB Leerink 10th Annual Global Healthcare Conference - PRNewswireCuris to Present at SVB Leerink 10th Annual Global Healthcare Conference - PRNewswire
prnewswire.com - February 19 at 12:15 PM
Curis to Present at SVB Leerink 10th Annual Global Healthcare ConferenceCuris to Present at SVB Leerink 10th Annual Global Healthcare Conference
finance.yahoo.com - February 19 at 12:15 PM
Curis (NASDAQ:CRIS)  Shares Down 5.1% Curis (NASDAQ:CRIS) Shares Down 5.1%
americanbankingnews.com - February 18 at 7:26 PM
How Many Curis, Inc. (NASDAQ:CRIS) Shares Do Institutions Own? - Yahoo FinanceHow Many Curis, Inc. (NASDAQ:CRIS) Shares Do Institutions Own? - Yahoo Finance
finance.yahoo.com - February 18 at 7:49 AM
How Many Curis, Inc. (NASDAQ:CRIS) Shares Do Institutions Own?How Many Curis, Inc. (NASDAQ:CRIS) Shares Do Institutions Own?
finance.yahoo.com - February 17 at 11:41 AM
Curis Doses First Patient in Phase 1 Study of CA-4948 in Combination with Ibrutinib in Patients with Relapsed or Refractory Hematologic Malignancies - Yahoo FinanceCuris Doses First Patient in Phase 1 Study of CA-4948 in Combination with Ibrutinib in Patients with Relapsed or Refractory Hematologic Malignancies - Yahoo Finance
finance.yahoo.com - February 11 at 2:33 PM
Curis (NASDAQ:CRIS) Shares Gap Up to $9.76Curis (NASDAQ:CRIS) Shares Gap Up to $9.76
americanbankingnews.com - February 11 at 1:45 PM
Curis Doses First Patient In Phase 1 Study Of CA-4948 - NasdaqCuris Doses First Patient In Phase 1 Study Of CA-4948 - Nasdaq
nasdaq.com - February 9 at 5:45 PM
Curis Doses First Patient in Phase 1 Study of CA-4948 in Combination with Ibrutinib in Patients with Relapsed or Refractory Hematologic Malignancies - PRNewswireCuris Doses First Patient in Phase 1 Study of CA-4948 in Combination with Ibrutinib in Patients with Relapsed or Refractory Hematologic Malignancies - PRNewswire
prnewswire.com - February 9 at 12:45 PM
Indapta Therapeutics Announces Key Management Team Appointments to Advance into Clinical Trials in 2021 - StreetInsider.comIndapta Therapeutics Announces Key Management Team Appointments to Advance into Clinical Trials in 2021 - StreetInsider.com
streetinsider.com - February 3 at 1:49 PM
Curis Initiates Phase 2 LUCAS Study Of CA-4948 For Treatment Of Anemia - NasdaqCuris Initiates Phase 2 LUCAS Study Of CA-4948 For Treatment Of Anemia - Nasdaq
nasdaq.com - February 2 at 7:09 PM
Curis Announces Initiation of Investigator-Sponsored Phase 2 LUCAS Study of CA-4948 for the Treatment of Anemia in Patients with Very Low, Low, or Intermediate-Risk Myelodysplastic Syndromes - PRNewswireCuris Announces Initiation of Investigator-Sponsored Phase 2 LUCAS Study of CA-4948 for the Treatment of Anemia in Patients with Very Low, Low, or Intermediate-Risk Myelodysplastic Syndromes - PRNewswire
prnewswire.com - February 2 at 9:07 AM
Curis Announces Initiation of Investigator-Sponsored Phase 2 LUCAS Study of CA-4948 for the Treatment of Anemia in Patients with Very Low, Low, or Intermediate-Risk Myelodysplastic SyndromesCuris Announces Initiation of Investigator-Sponsored Phase 2 LUCAS Study of CA-4948 for the Treatment of Anemia in Patients with Very Low, Low, or Intermediate-Risk Myelodysplastic Syndromes
finance.yahoo.com - February 2 at 9:07 AM
Taseko Announces Upsizing and Pricing of Senior Secured Notes Offering - Yahoo FinanceTaseko Announces Upsizing and Pricing of Senior Secured Notes Offering - Yahoo Finance
finance.yahoo.com - January 27 at 10:27 PM
RUBY Stock Price, Rubius Therapeutics Stock Quotes and News - BenzingaRUBY Stock Price, Rubius Therapeutics Stock Quotes and News - Benzinga
benzinga.com - January 27 at 5:26 PM
Taseko Announces Upsizing and Pricing of Senior Secured Notes Offering - PRNewswireTaseko Announces Upsizing and Pricing of Senior Secured Notes Offering - PRNewswire
prnewswire.com - January 27 at 5:26 PM
Curis Inc.: Understanding CI-8993 And VISTA - Seeking AlphaCuris Inc.: Understanding CI-8993 And VISTA - Seeking Alpha
seekingalpha.com - January 27 at 12:26 PM
Curis to Present at B. Riley Securities Virtual Oncology Investor Conference - Yahoo FinanceCuris to Present at B. Riley Securities Virtual Oncology Investor Conference - Yahoo Finance
finance.yahoo.com - January 14 at 3:42 PM
Curis to Present at B. Riley Securities Virtual Oncology Investor ConferenceCuris to Present at B. Riley Securities Virtual Oncology Investor Conference
finance.yahoo.com - January 14 at 3:42 PM
Curis to Present at H.C. Wainwright & Co. Bioconnect 2021 Virtual Conference - Yahoo FinanceCuris to Present at H.C. Wainwright & Co. Bioconnect 2021 Virtual Conference - Yahoo Finance
finance.yahoo.com - January 5 at 12:26 PM
Curis to Present at H.C. Wainwright & Co. Bioconnect 2021 Virtual ConferenceCuris to Present at H.C. Wainwright & Co. Bioconnect 2021 Virtual Conference
finance.yahoo.com - January 5 at 12:26 PM
Curis Inc.: Understanding CA-4948 And IRAK-4 Inhibition - Seeking AlphaCuris Inc.: Understanding CA-4948 And IRAK-4 Inhibition - Seeking Alpha
seekingalpha.com - December 23 at 8:03 PM
Curis Inc.: Understanding CA-4948 And IRAK-4 InhibitionCuris Inc.: Understanding CA-4948 And IRAK-4 Inhibition
seekingalpha.com - December 23 at 4:53 PM
CytomX Therapeutics Appoints Dr. Mani Mohindru to Board of DirectorsCytomX Therapeutics Appoints Dr. Mani Mohindru to Board of Directors
finance.yahoo.com - December 22 at 5:06 PM
Curis Announces Closing of Public Offering of Common Stock with $169.6 Million in Gross Proceeds, Including Full Exercise of Underwriters Option to Purchase Additional Shares - Yahoo FinanceCuris Announces Closing of Public Offering of Common Stock with $169.6 Million in Gross Proceeds, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - Yahoo Finance
finance.yahoo.com - December 14 at 8:52 PM
Curis Announces Closing of Public Offering of Common Stock with $169.6 Million in Gross Proceeds, Including Full Exercise of Underwriters Option to Purchase Additional Shares - PRNewswireCuris Announces Closing of Public Offering of Common Stock with $169.6 Million in Gross Proceeds, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - PRNewswire
prnewswire.com - December 14 at 10:50 AM
Curis Announces Closing of Public Offering of Common Stock with $169.6 Million in Gross Proceeds, Including Full Exercise of Underwriters Option to Purchase Additional SharesCuris Announces Closing of Public Offering of Common Stock with $169.6 Million in Gross Proceeds, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - December 14 at 10:50 AM
Curis (CRIS) Surges: Stock Moves 5% Higher - NasdaqCuris (CRIS) Surges: Stock Moves 5% Higher - Nasdaq
nasdaq.com - December 11 at 12:00 PM
Curis (CRIS) Surges: Stock Moves 5% HigherCuris (CRIS) Surges: Stock Moves 5% Higher
finance.yahoo.com - December 11 at 12:00 PM
Is CRIS A Good Stock To Buy Now?Is CRIS A Good Stock To Buy Now?
finance.yahoo.com - December 11 at 1:59 AM
Stock Alert: Curis Shares Gain After Pricing Of Public Offering - NasdaqStock Alert: Curis Shares Gain After Pricing Of Public Offering - Nasdaq
nasdaq.com - December 10 at 3:55 PM
Curis Announces Pricing of Public Offering of Common Stock - PRNewswireCuris Announces Pricing of Public Offering of Common Stock - PRNewswire
prnewswire.com - December 10 at 3:55 PM
Curis prices equity offering at $5.75/share - Seeking AlphaCuris prices equity offering at $5.75/share - Seeking Alpha
seekingalpha.com - December 10 at 5:51 AM
Curis (CRIS) Stock Is up 420% in Two Days. How Much Higher Can It Go? - Yahoo FinanceCuris (CRIS) Stock Is up 420% in Two Days. How Much Higher Can It Go? - Yahoo Finance
finance.yahoo.com - December 9 at 7:51 PM
Curis (CRIS) Skyrockets on Promising Phase I Pipeline Updates - Yahoo FinanceCuris (CRIS) Skyrockets on Promising Phase I Pipeline Updates - Yahoo Finance
finance.yahoo.com - December 9 at 7:51 PM
Curis (CRIS) Stock Is up 420% in Two Days. How Much Higher Can It Go?Curis (CRIS) Stock Is up 420% in Two Days. How Much Higher Can It Go?
finance.yahoo.com - December 9 at 7:51 PM
Curis Announces Pricing of Public Offering of Common Stock - Yahoo FinanceCuris Announces Pricing of Public Offering of Common Stock - Yahoo Finance
finance.yahoo.com - December 9 at 2:50 PM
Curis (CRIS) Skyrockets on Promising Phase I Pipeline UpdatesCuris (CRIS) Skyrockets on Promising Phase I Pipeline Updates
finance.yahoo.com - December 9 at 2:50 PM
Curis Announces Pricing of Public Offering of Common StockCuris Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - December 9 at 2:50 PM
Curis readies equity raise - Seeking AlphaCuris readies equity raise - Seeking Alpha
seekingalpha.com - December 8 at 9:16 PM
Curis skyrockets 448% after encouraging phase 1 data for leukemia treatment - Business InsiderCuris skyrockets 448% after encouraging phase 1 data for leukemia treatment - Business Insider
businessinsider.com - December 8 at 9:16 PM
Curis, Lexicon Pharmaceuticals leads healthcare gainers; Obalon Therapeutics, Arcturus Therapeutics among major losers - Seeking AlphaCuris, Lexicon Pharmaceuticals leads healthcare gainers; Obalon Therapeutics, Arcturus Therapeutics among major losers - Seeking Alpha
seekingalpha.com - December 8 at 4:16 PM
Return On Capital Employed Overview: Curis - BenzingaReturn On Capital Employed Overview: Curis - Benzinga
benzinga.com - December 8 at 4:16 PM
Why Is It Moving? Looking Into Why Curiss Stock is Trading Higher Today - BenzingaWhy Is It Moving? Looking Into Why Curis's Stock is Trading Higher Today - Benzinga
benzinga.com - December 8 at 4:16 PM
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.